Wolwo Bio-Pharmaceutical (300357.SZ): Clinical trial application for S01D tablets approved

Zhitong Finance APP news, Wolwo Bio-Pharmaceutical (300357.SZ) issued an announcement that recently, the company downloaded and obtained the "Drug Clinical Trial Approval Notice" from the government service portal website of the National Medical Products Administration. The clinical trial application for the S01D tablet submitted by the company has been approved. The drug is intended for the treatment of adult drug-resistant pulmonary tuberculosis. The approval of the drug's clinical trial application is an important R&D milestone for the company in the field of anti-drug-resistant pulmonary tuberculosis drugs.